199 related articles for article (PubMed ID: 486283)
1. Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
Benedict CR; Grahame-Smith DG
Br Heart J; 1979 Aug; 42(2):214-20. PubMed ID: 486283
[TBL] [Abstract][Full Text] [Related]
2. Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique.
Siggers DC; Salter C; Fluck DC
Br Heart J; 1971 Nov; 33(6):878-83. PubMed ID: 4107638
[No Abstract] [Full Text] [Related]
3. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.
Oswald GA; Smith CC; Delamothe AP; Betteridge DJ; Yudkin JS
Br Heart J; 1988 Jun; 59(6):663-71. PubMed ID: 2969254
[TBL] [Abstract][Full Text] [Related]
4. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage.
Benedict CR; Grahame-Smith DG
Q J Med; 1978 Jan; 47(185):1-20. PubMed ID: 674546
[TBL] [Abstract][Full Text] [Related]
5. [Importance of correlating catecholamines and acetylcholine in the acute period of complicated and uncomplicated myocardial infarct].
Shpak LV
Kardiologiia; 1978 Jul; 18(7):62-7. PubMed ID: 682416
[TBL] [Abstract][Full Text] [Related]
6. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
[TBL] [Abstract][Full Text] [Related]
7. [Free-radical lipid peroxidation in acute myocardial infarction complicated by cardiogenic shock].
Rysmendiev AZh; Tukesheva BSh; Grabarova IP; Iskakov KM
Kardiologiia; 1986 May; 26(5):37-40. PubMed ID: 3735916
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-beta-hydroxylase, adrenaline, noradrenaline and dopamine in the venous blood of adrenal gland of man: a comparison with levels in the periphery of the circulation.
Planz G; Planz R
Experientia; 1979 Feb; 35(2):207-8. PubMed ID: 421831
[TBL] [Abstract][Full Text] [Related]
9. [Plasma and urine catecholamine levels in patients with myocardial infarct].
Oganov RG
Kardiologiia; 1971 May; 11(5):16-26. PubMed ID: 5126314
[No Abstract] [Full Text] [Related]
10. [Increased plasma noradrenaline values in severe atopic eczema].
Ionescu G; Kiehl R
Z Hautkr; 1989 Nov; 64(11):1036-7. PubMed ID: 2609712
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
[TBL] [Abstract][Full Text] [Related]
12. The effect of a six-day ski-hike on plasma catecholamine concentrations and on their response to submaximal exercise.
Vuori I; Marniemi J; Rahkila P; Vainikka M
Med Biol; 1979 Oct; 57(5):362-6. PubMed ID: 522524
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the adrenergic response by measurement of catecholamines and activity of dopamine-beta-hydroxylase (D-beta-B) in arterial capillary blood].
Guilland JC; Begue RJ; Dumas JP; Malval M; Klepping J
C R Seances Soc Biol Fil; 1979; 173(4):781-7. PubMed ID: 160824
[TBL] [Abstract][Full Text] [Related]
14. Progressive nature of myocardial injury in selected patients with cardiogenic shock.
Gutovitz AL; Sobel BE; Roberts R
Am J Cardiol; 1978 Mar; 41(3):469-75. PubMed ID: 626124
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.
Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A
Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869
[TBL] [Abstract][Full Text] [Related]
16. Possible interaction of platelets and adrenaline in the early phase of myocardial infarction.
Seitz R; Leising H; Liebermann A; Rohner I; Gerdes H; Egbring R
Res Exp Med (Berl); 1987; 187(5):385-93. PubMed ID: 2963360
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial sympathetic activity in coronary heart disease.
Michelet MC; Lasserre B; Mievis E; Perrenoud JJ; Roth M; Rutishauser W
Cardiology; 1981; 68(4):206-17. PubMed ID: 7326668
[TBL] [Abstract][Full Text] [Related]
18. Increased arterial adrenaline is related to pain in uncomplicated myocardial infarction.
Husebye E; Kjeldsen SE; Lande K; Gjesdal K; Os I; Eide I
J Intern Med; 1990 Dec; 228(6):617-22. PubMed ID: 2149143
[TBL] [Abstract][Full Text] [Related]
19. Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.
Jarai R; Huber K; Bogaerts K; Sinnaeve PR; Ezekowitz J; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Crit Care Med; 2010 Sep; 38(9):1793-801. PubMed ID: 20562693
[TBL] [Abstract][Full Text] [Related]
20. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
